According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031.
Bladder cancer remains one of the most prevalent urological malignancies worldwide, with non-muscle invasive...
According to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031.
Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...
According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031.
Endometrial cancer, classified under gynecologic malignancies, originates in the...
Executive Summary Synthetic Lethality Drug Market Size and Share Analysis Report
CAGR Value
The global Synthetic Lethality Drug market size was valued at USD 1.93 billion in 2025 and is expected to reach USD 8.07 billion by 2033, at a CAGR of 19.60% during the forecast period
This Synthetic Lethality Drug Market research report guides the...
The Oncology Small Molecule Drugs Market is evolving rapidly as pharmaceutical innovators and healthcare systems worldwide intensify efforts against cancer with advanced therapeutics and strategic investments. According to the latest Oncology Small Molecule Drugs Market report by The Insight Partners, this market is poised to grow at a compound annual growth rate (CAGR) of 5.6% from 2025 to...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek